Stay updated on ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer
Sign up to get notified when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.
Latest updates to the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page
- ChecktodayNo Change Detected
- CheckyesterdayNo Change Detected
- Check2 days agoNo Change Detected
- Check3 days agoNo Change Detected
- Check5 days agoChange DetectedThe website has been updated to version v2.10.0, adding support for 3 more conditions and noting that the study now includes 238 locations, while the previous version v2.9.7 has been removed.SummaryDifference0.3%
- Check11 days agoChange DetectedThe website has been updated with a new revision v2.9.7, replacing the estimated last update posted with the actual last update posted information.SummaryDifference0.1%
- Check14 days agoChange DetectedThe website has been updated with new information as of July 12, 2024, including actual data and the last update posted on May 20, 2024.SummaryDifference0.7%
- Check16 days agoChange DetectedDifference0.2%
- Check17 days agoChange DetectedDifference0.1%
- Check23 days agoChange DetectedThe value Ovarian Epithelial Cancer Fallopian Tube Cancer has recently changed to Fallopian Tube Cancer Ovarian Epithelial Cancer. This change represents a reversal in the order of the terms, indicating a switch in the primary focus or emphasis of the study from ovarian epithelial cancer to fallopian tube cancer.SummaryDifference0.2%
Stay in the know with updates to ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer
Enter your email address, and we'll notify you when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.